Equasens(0R9T)
EUR --+0.00%
Reward54Moderate
Risk21Low
📊75%Data
Strong 16% profit margin · 3.2% dividend yield
0R9T
+0.0 · +0.00%
EUR · LSE
Equasens |
Defensive Anchor
Market Cap:580.54M
ℹ️
Reward Rating
54
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
21
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0R9T to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Equasens?

Equasens Société anonyme provides healthcare IT solutions in Europe.

0R9T · Verdict

Moderate reward · low risk

0R9T stands out on balance sheet and profitability, but watch the growth signal.

Based on 88% data coverage

0R9T · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet94/100

    Current ratio 1.77

  • Profitability85/100

    17% net margin · 16% ROE

  • Volatility80/100

    Top decile vs peers

  • Valuation72/100

    Above average

  • Cash flow71/100

    20% free-cash-flow margin

Watchouts 1

  • Growth33/100

    Rev +3.4% CAGR · earnings -5.4%

Model-based scoring. For information only — not financial advice.

What is Equasens?

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. The company is listed on the LSE in UK, with a market capitalisation of 580.54M, and a P/E ratio of 0.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (54)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap580.54M
P/E Ratio0.1481
Dividend Yield3.19%
52 Week High53.2
52 Week Low34
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding15M
No. of Employees1,400
IndustryN/A
ExchangeLSE
Beta0.588
CurrencyEUR